Acute promyelocytic leukemia represents 5–10% of AML and is defined by the cytogenetic abnormality t (15; 17), which results in the PML-RAR alpha fusion oncogene and its encoded oncoprotein. The gene discussed is RARA; the disease is acute promyelocytic leukemia.